Year: 2020

SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the following November investor conferences.Stifel 2020 Virtual Healthcare ConferencePresentation on Wednesday, November 18, 2020, at 4:00 pm ESTCanaccord Genuity MedTech & Diagnostics ForumFireside Chat on Thursday, November 19, 2020, at 11:30 am ESTA link to the live webcast of the Stifel presentation will be available on the Exagen website at https://investors.exagen.com/.About Exagen Inc.Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has...

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

RALEIGH, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) — Martin Marietta Materials, Inc. (NYSE:MLM) today announced the appointment of Anthony R. Foxx as an independent member to its Board of Directors, effective November 6, 2020. With Mr. Foxx’s appointment, the Martin Marietta Board is comprised of 11 directors, 10 of whom are independent and six of whom have joined since 2016. Mr. Foxx will serve on Martin Marietta’s Finance Committee.Mr. Foxx is currently chief policy officer and advisor to the president and chief executive officer of Lyft, which he joined in October 2018. Prior to joining Lyft, he served as the seventeenth United States Secretary of Transportation from 2013 to 2017. The Senate confirmed the nomination of Mr. Foxx to the Secretary of Transportation by a vote of 100-0. During his time as the Secretary of Transportation,...

 Virtual data presentation at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting on Wednesday, November 11, 2020Heidelberg, Germany, November 9, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that preclinical data – generated through a collaboration with The University of Texas MD Anderson Cancer Center and Washington University School of Medicine – will be the focus of an oral presentation at the virtual Annual Meeting of the Society for Immunotherapy of Cancer (SITC), identifying promising combinations of Innate Cell Engager (ICE®) AFM13 with cytokine-activated adult blood or cord blood natural killer (NK) cells against CD30-positive hematological malignancies. Nancy D. Marin, PhD, of Washington...

— ORR of 64% Observed in Patients with >2L HER2 Positive Gastric/Gastroesophageal Junction Cancer — ORR of 75% and One Complete Response Observed in Patients with 1L Head and Neck Cancer— ALX Oncology to Host Conference Call on November 16 at 5:00pm ESTBURLINGAME, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) —  ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced new results from ASPEN-01, the ALX148 Phase 1b study, evaluating patients with solid tumor malignancies at the Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting [abstract 404].ALX Oncology reports new preliminary data from the gastric/gastroesophageal junction cancer (“GC”) patient cohort receiving ALX148 plus trastuzumab...

FLEMING ISLAND, FLORIDA, Nov. 09, 2020 (GLOBE NEWSWIRE) — OBITX, Inc., (OTCMKTS: OBTX) located in Fleming Island, Florida, has seen its current-cryptocurrency assets grow 510% in fair market value during the quarter ending October 31, 2020. In addition, the company has seen its non-current cryptocurrency assets grow 253% in fair market value during the same period.  The Company classifies its cryptocurrencies as either current or non-current intangible assets. Current cryptocurrency assets are identified as those assets with substantial liquidity to support a liquidation of the asset held, while non-current cryptocurrencies are those assets which could not support liquidation of the asset held.OBITX current-cryptocurrency is in the “HEX” token, touted as the first high interest blockchain certificate of deposit.  Robert Adams, a...